Faculty Profiles - NISHIDA, Yoshihiro

Papers - NISHIDA, Yoshihiro

Division display 321 - 340 of about 708 ／ All the affair displays >>

Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review. Reviewed

Koike H, Hamada S, Sakai T, Shimizu K, Yoshida M, Nishida Y.

Jpn J Clin Oncol. Vol. 50 ( 9 ) page： 1032 - 1036 2020.9

Forced Expression of KIAA1199, a Novel Hyaluronidase, Inhibits Tumorigenicity of Low-Grade Chondrosarcoma Reviewed Open Access

Koike H , Nishida Y, Shinomura T, Zhuo L, Hamada S, Ikuta K, Ito K, Kimata K, Ushida T, Ishiguro N

J Orthop Res. Vol. 38 ( 9 ) page： 1942 - 1951 2020.9

膝蓋骨および大腿四頭筋の広範欠損に対して大腿筋膜付き前外側大腿皮弁による機能的再建を行った1例 Reviewed

伊藤弘幸, 高成啓介, 中村優, 蛯沢克巳, 神戸未来, 内堀貴文, 宮永亨, 新井英介, 西田佳弘, 亀井讓

日本形成外科学会会誌 Vol. 40 ( 9 ) page： 489-496 2020.9

膝蓋骨および大腿四頭筋の広範欠損に対して大腿筋膜付き前外側大腿皮弁による機能的再建を行った1例 Reviewed

伊藤弘幸, 高成啓介, 中村優, 蛯沢克己, 神戸未来, 内堀貴文, 宮永亨, 新井英介, 西田佳弘, 亀井譲

日本形成外科学会会誌 Vol. 40 ( 9 ) page： 489 - 496 2020.9

Cardiac metastases from primary myxoid liposarcoma of the thigh: a case report. Reviewed Open Access

Ikuta K, Sakai T, Koike H, Okada T, Imagama S, Nishida Y.

World J Surg Oncol. Vol. 18 ( 1 ) page： 227 - 227 2020.8

Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institution. Reviewed

Kenta Ishii, Yukihiro Yokoyama, Yoshihiro Nishida, Suguru Yamada, Yasuhiro Kodera, Naoto Sassa, Momokazu Gotoh, Masato Nagino

Jpn J Clin Oncol Vol. - ( - ) page： 10.1093/jjco/hyaa126. - 1418 2020.7

Low energy irradiation of narrow-range UV-LED prevents osteosarcopenia associated with vitamin D deficiency in senescence-accelerated mouse prone 6. Reviewed

Kazuya Makida, Yoshihiro Nishida, Daigo Morita, Satoshi Ochiai, Yoshitoshi Higuchi, Taisuke Seki, Kunihiro Ikuta, Naoki Ishiguro

Sci Rep. Vol. 10 ( 1 ) page： 11892 2020.7

Functional evaluation following deltoid muscle resection in patients with soft tissue sarcoma Reviewed Open Access

Hamada S, Nishida Y, Takanari K, Ota T, Urakawa H, Ikuta K, Sakai T, Tsukushi S, Kamei Y, Ishiguro N

Jap J Clin Oncol. Vol. 50 ( 7 ) page： 772 - 778 2020.7

Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas Reviewed

Urakawa H, Kawai A, Goto T, Hiraga H, Ozaki T, Tsuchiya H, Nakayama R, Naka N, Matsumoto Y, Kobayashi E, Okuma T, Kunisada T, Ando M, Ueda T, Nishida Y

Cancer Sci. Vol. - ( - ) page： 10.1111/cas.14542. - 3312 2020.6

Risk Factors of Local Recurrence after Surgery in Extra-Abdominal Desmoid-Type Fibromatosis:A Multicenter Study in Japan. Reviewed

Nishida Y, Hamada S, Kawai A, Kunisada T, Ogose A, Matsumoto Y, Ae K, Toguchida J, Ozaki T, Hirakawa A, Motoi T, Sakai T, Kobayashi E, Gokita T, Okamoto T, Matsunobu T, Shimizu K, Koike H

Cancer Sci. Vol. - ( - ) page： 10.1111/cas.14528. - 2942 2020.6

Short physical performance battery discriminates clinical outcomes in hospitalized patients aged 75 years and over. Reviewed

Fujita K, Nakashima H, Kako M, Shibata A, Yu-Ting C, Tanaka S, Nishida Y, Kuzuya M

Arch Gerontol Geriatr. Vol. 90 page： 104155 2020.6

Clinical value of serum bone resorption markers for predicting clinical outcomes after use of bone modifying agents in metastatic bone tumors:A prospective cohort study. Reviewed

Urakawa H,Ando Y,Hase T,Kikumori T,Arai E,Maeda O,Mitsuma A,Sugishita M,Shimokata T,Ikuta K,Ishiguro N,Nishida Y.

Int J Cancer. Vol. 146 ( 12 ) page： 3504 - 3515 2020.6

A case of retroperitoneal dedifferentiated liposarcoma successfully treated by neoadjuvant chemotherapy and subsequent surgery. Reviewed Open Access

Yokoyama Y, Nishida Y, Ikuta K, Nagino M.

Surg Case Rep. Vol. 6 ( 1 ) page： 105 - 105 2020.5

Definitive radiation therapy in patients with unresectable desmoid tumors: A systematic review. Reviewed International journal Open Access

Matsunobu T, Kunisada T, Ozaki T, Iwamoto Y, Yoshida M, Nishida Y

Jpn J Clin Oncol Vol. 50 ( 5 ) page： 568 - 573 2020.5

Language：English Publishing type：Research paper (scientific journal)

BACKGROUND: Desmoid tumors are rare soft tissue tumors. Wide local excision has been the standard surgical treatment for desmoid tumors. However, this procedure results in high local recurrence rates, so non-surgical treatments should be considered. The aim of this systematic review was to evaluate the effect of radiation therapy on patients with desmoid tumors, especially those with unresectable disease. METHODS: We evaluated studies published between 1 January 1990 and 31 August 2017 and cited in PubMed and Ichushi (in Japanese). All studies evaluating the effect of radiation therapy on desmoid tumors were included. Data regarding radiation dose, recurrence and adverse events were recorded. RESULTS: Among 218 identified studies, only 6 were finally included in this review. Local control was achieved in 253 of 317 patients with unresectable or unresected tumors who underwent definitive radiation therapy (the crude rate of local control was 79.8%). Toxicity was evaluated in patients who underwent definitive radiation therapy or surgery plus radiation therapy. One of the most common acute complications was skin toxicity. Frequent late complications of radiation therapy included fibrosis/contracture/joint stiffness, skin disorders, lymphedema and pain. Six patients developed secondary malignancies in the radiation field. CONCLUSIONS: In patients treated unsuccessfully with surgery, watchful waiting and pharmacotherapy, radiation therapy may be an option as salvage therapy because of the high rate of local control. Because desmoid tumors frequently develop in young individuals, children and young patients who receive radiation therapy for the treatment of desmoid tumors should be followed up on a long-term basis with periodic monitoring for late radiation toxicities.

DOI： 10.1093/jjco/hyaa007

Web of Science

Scopus

PubMed

全身性強皮症および多発性筋炎のオーバーラップ症候群に合併したⅡ型呼吸不全に対して呼吸器リハビリテーション治療が有効であった1例 Reviewed Open Access

岡田貴士, 門野泉, 金野鈴奈, 杉山純也, 菱田愛加, 西田佳弘, 杉浦英志

The Japanese Journal of Rehabilitation Medicine Vol. 57 ( 5 ) page： 468 - 473 2020.5

Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departments. Reviewed

Sassa N, Yokoyama Y, Nishida Y, Yamada S, Uchida H, Kajiyama H, Nagino M, Kodera Y, Gotoh M

Int J Clin Oncol Vol. 25 ( 5 ) page： 929-936 - 936 2020.5

How Many Steps Per Day are Necessary to Prevent Postoperative Complications Following Hepato-Pancreato-Biliary Surgeries for Malignancy? Reviewed

Nakajima H, Yokoyama Y, Inoue T, Nagaya M, Mizuno Y, Kayamoto A, Nishida Y, Nagino M

Ann Surg Oncol Vol. 27 ( 5 ) page： 1387 - 1397 2020.5

Usefulness of surgical treatment for asymptomatic patients with extra-peritoneal desmoid-type fibromatosis: A systematic review and meta-analysis. Reviewed International journal Open Access

Kito M, Ogose A, Yoshida M, Nishida Y

Jpn J Clin Oncol Vol. 50 ( 5 ) page： 574 - 580 2020.5

Language：English Publishing type：Research paper (scientific journal)

OBJECTIVE: The purpose of this systematic review is to assess and compare the efficacy of surgical treatment for patients with asymptomatic extra-peritoneal desmoid-type fibromatosis to the wait-and-see policy by evaluating (1) the exacerbation rate (exacerbation; recurrence after surgery or progressive disease following non-surgical treatment) and (2) treatment-associated complications in extra-peritoneal desmoid-type fibromatosis. METHODS: We evaluated documents published between 1 January 1990 and 31 August 2017. The risk of bias in the selected literature was analyzed using the Cochrane Collaboration Risk of Bias Tool. Quality of evidence was evaluated using Grading of Recommendation, Assessment, Development and Evaluation approach. RESULTS: One prospective cohort study, four case-control studies and five case series studies were identified. Meta-analysis was performed to evaluate the exacerbation rate after treatment on one prospective cohort study and four case-control studies. In comparing surgical and non-surgical treatments, the exacerbation rate was significantly higher in the surgical treatment group (odds ratio: 1.32, 95% confidence interval 1.01-1.73, P = 0.05). However, in the case series study, the recurrence rate was 23.4% for the surgical treatment group, while the progressive disease rate was 28.1% for the non-surgical treatment group. The postoperative complication rates associated with surgical treatment in the two studies were 20.8 and 17.2%, respectively. CONCLUSIONS: When considering the exacerbation rate, non-surgical treatment might be appropriate for asymptomatic patients with extra-peritoneal desmoid-type fibromatosis. However, if patients with tumor-related symptoms opt for surgery, including those who face difficulties due to the presence of tumors, it is important to fully explain to them the possibility that the recurrence rate and treatment-associated functional failures may increase depending on the site of occurrence.

DOI： 10.1093/jjco/hyaa009

Web of Science

Scopus

PubMed

全身性強皮症および多発性筋炎のオーバーラップ症候群に合併したⅡ型呼吸不全に対して呼吸器リハビリテーション治療が有効であった1例 Open Access

岡田貴士, 門野泉, 金野鈴奈, 杉山純也, 菱田愛加, 西田佳弘, 杉浦英志

The Japanese Journal of Rehabilitation Medicine Vol. 57 ( 5 ) page： 468-473 2020.5

Efficacy of low dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis : A systematic review. Reviewed

Shimizu K, Hamada S, Sakai T, Koike H, Yoshida M, Nishida Y

Jpn J Clin Oncol Vol. 50 ( 4 ) page： 419-424 - 424 2020.4

　 PREV - NEXT 　

<NISHIDA, Yoshihiro>

Papers - NISHIDA, Yoshihiro